An ascorbic acid-decorated nanostructured surface on titanium inhibits breast cancer development and promotes osteogenesis

Biomed Mater. 2023 Dec 1;19(1). doi: 10.1088/1748-605X/ad0fa2.

Abstract

The chest wall is the most frequent metastatic site of breast cancer (BC) and the metastasis usually occurs in a solitary setting. Chest wall resection is a way to treat solitary BC metastasis, but intraoperative bone defects and local tumor recurrence still affect the life quality of patients. Titanium-based prostheses are widely used for chest wall repair and reconstruction, but their inherent bio-inertness makes their clinical performance unfavorable. Nanostructured surfaces can give titanium substrates the ability to excellently modulate a variety of cellular functions. Ascorbic acid is a potential stimulator of tumor suppression and osteogenic differentiation. An ascorbic acid-decorated nanostructured titanium surface was prepared through alkali treatment and spin-coating technique and its effects on the biological responses of BC cells and osteoblasts were assessed. The results exhibited that the nanorod structure and ascorbic acid synergistically inhibited the proliferation, spreading, and migration of BC cells. Additionally, the ascorbic acid-decorated nanostructured surface significantly promoted the proliferation and osteogenic differentiation of osteoblasts. This work may provide valuable references for the clinical application of titanium materials in chest wall reconstruction after the resection of metastatic BC.

Keywords: ascorbic acid; breast cancer; nanostructure; osteogenesis; titanium.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms*
  • Cell Differentiation
  • Female
  • Humans
  • Nanostructures* / chemistry
  • Osteoblasts
  • Osteogenesis
  • Surface Properties
  • Titanium / chemistry

Substances

  • Titanium